Paul Andrew Moore serves as Executive at Zymeworks Inc., where they oversee executive responsibilities. Since joining the company, Paul Andrew Moore has executed 3 insider transactions totaling $105.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 8, 2024 involved selling 2,339 shares valued at $26.2K.
Paul Andrew Moore currently holds 7,367 shares of Zymeworks Inc. (ZYME), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Andrew Moore has been a net seller of ZYME stock. They have purchased $0 and sold $105.7K worth of shares.
Paul Andrew Moore's most recent insider trade was on Jan 8, 2024, when they sold 2,339 shares at $11.22 per share.
Get notified when new Form 4 filings are submitted
| $10.65 |
| Discretionary |
| Jan 5, 2024 | ZYME | $0 | Option Exercise | 17,166 | $N/A | Discretionary |